Manmeet Singh Soni's Net Worth
$49.9 Million
Who is Manmeet Singh Soni?
Manmeet Singh Soni has an estimated net worth of $49.9 Million. This is based on reported shares across multiple companies, which include ALNYLAM PHARMACEUTICALS, INC., ARENA PHARMACEUTICALS INC, REATA PHARMACEUTICALS INC, Summit Therapeutics Inc., Pulse Biosciences, Inc., ARIAD PHARMACEUTICALS INC, and PHARMACYCLICS INC.
SEC CIK
Manmeet Singh Soni's CIK is 0001569769
Past Insider Trading and Trends
2023 was Manmeet Singh Soni's most active year for acquiring shares with 13 total transactions. Manmeet Singh Soni's most active month to acquire stocks was the month of December. 2023 was Manmeet Singh Soni's most active year for disposing of shares, totalling 27 transactions. Manmeet Singh Soni's most active month to dispose stocks was the month of May. 2023 saw Manmeet Singh Soni paying a total of $11,135,499.20 for 17,506,178 shares, this is the most they've acquired in one year. In 2015 Manmeet Singh Soni cashed out on 201,971 shares for a total of $21,890,954.27, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALNYLAM PHARMACEUTICALS, INC. (ALNY) Snapshot price: $172.18
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
∞
| 83 |
—
|
—
| 83 |
Jul 25 - Aug 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARENA PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.90% | -304.00 |
$62.74 | -$19,072.96 | 5.9K |
Scheduled
|
Jun 17
| ||
Form 4
| +22.00% | 1.12K |
$60.12 | -$79,779.24 | 6.21K |
Scheduled
|
Jun 12 - Jun 15
| ||
Form 4
| +39.37% | 1.44K |
$55.89 | -$68,021.89 | 5.09K |
Scheduled
|
Jun 13 - Jun 14
| ||
Form 4
|
∞
| 3.65K |
—
|
—
| 3.65K |
Dec 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
REATA PHARMACEUTICALS INC No price found
COO, CFO and President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -62.62K |
—
|
—
|
0
|
Sep 26
| |||
Form 4
| -2.73% | -1.75K |
$168.41 | -$295,565.69 | 62.62K |
Aug 16
| |||
Form 4
|
—
|
0
|
$164.62 | -$12,346,297.50 | 64.38K |
Jul 28
| |||
Form 4
| +10.28% | 6K |
—
|
—
| 64.38K |
Jul 6
| |||
Form 4
| -49.75% | -57.80K |
$65.02 | -$7,820,639.95 | 58.38K |
Jun 12 - Jun 13
| |||
Form 4
| -16.00% | -22.13K |
$84.45 | -$1,869,150.48 | 116.17K |
May 15 - May 16
| |||
Form 4
| +56.62% | 50K |
—
|
—
| 138.3K |
May 5
| |||
Form 4
| -0.70% | -622.00 |
$84.70 | -$52,680.29 | 88.3K |
Mar 7
| |||
Form 4
| -3.88% | -3.59K |
$87.97 | -$315,548.39 | 88.93K |
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
| +34.08% | 23.51K |
—
|
—
| 92.51K |
Jan 3
| |||
Form 4
| +263.16% | 50K |
—
|
—
| 69K |
Jan 3
| |||
Form 4
| +533.33% | 16K |
$26.22 | $419,564.80 | 19K |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
∞
| 3K |
$100.21 | $300,630.00 | 3K |
Aug 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Summit Therapeutics Inc. (SMMT) Snapshot price: $4.25
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 4
|
∞
| 2.98M |
$1.68 | $4,999,999.20 | 2.98M |
Oct 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pulse Biosciences, Inc. (PLSE) Snapshot price: $8.55
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||